REVOLUTION MEDICINES INC C/WTS 17/12/2026 (TO PUR COM)
RVMDW----
REVOLUTION MEDICINES INC C/WTS 17/12/2026 (TO PUR COM) (RVMDW)
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
News
- Unusual Whales · 6 hours ago
CAMP4 Therapeutics Secures Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of CMP-002 in Patients With SYNGAP1-Related Disorder
- Earnings Watch · May 6 at 03:13 PM
REVOLUTION MEDICINES INC C/WTS 17/12/2026 (TO PUR COM) | 8-K: FY2026 Q1 Revenue: USD 0
- StockTitan · Apr 14 at 03:41 PM
Revolution Medicines, Inc. Prices $2.0 Billion in Concurrent Upsized Offerings of Common Stock and Convertible Senior Notes | RVMD Stock News
- Barchart Option · Apr 13 at 02:03 PM
Revolution Medicines Soars on Phase 3 Trial Results. Is It Too Late to Buy?
- Earnings Watch · Feb 25 at 03:20 PM
REVOLUTION MEDICINES INC C/WTS 17/12/2026 (TO PUR COM) | 10-K: FY2025 Revenue: USD 0
- Earnings Watch · Feb 25 at 03:08 PM
REVOLUTION MEDICINES INC C/WTS 17/12/2026 (TO PUR COM) | 8-K: FY2025 Q4 Revenue: USD 0
